We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a pivotal Phase 3 study of its kidney drug Filspari...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.38 | -3.34259853182 | 280.62 | 298.01 | 270.01 | 555537 | 279.23423834 | DE |
4 | -8.78 | -3.13549032212 | 280.02 | 380.01 | 160.01 | 608601 | 281.08075677 | DE |
12 | -23.26 | -7.89813242784 | 294.5 | 380.01 | 160.01 | 684966 | 285.60123196 | DE |
26 | 30.94 | 12.8755722014 | 240.3 | 380.01 | 154 | 685704 | 273.38688303 | DE |
52 | -30.01 | -9.96182572614 | 301.25 | 380.01 | 152 | 740824 | 273.43621305 | DE |
156 | 1.47 | 0.544908625866 | 269.77 | 400 | 0.11 | 744771 | 280.62789579 | DE |
260 | 68.24 | 33.6157635468 | 203 | 400 | 0.11 | 801784 | 279.6402158 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions